Cargando…
Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016
A multicentre nationwide surveillance study was conducted in Greek hospitals to evaluate epidemiology of carbapenemase-producing Klebsiella pneumoniae clinical isolates, and their susceptibilities to last-line antibiotics. Methods: Minimum inhibitory concentrations (MICs) were evaluated by Etest, co...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167611/ http://dx.doi.org/10.2807/1560-7917.ES.2018.23.31.1700775 |
_version_ | 1783360235067408384 |
---|---|
author | Galani, Irene Karaiskos, Ilias Karantani, Irene Papoutsaki, Vassiliki Maraki, Sofia Papaioannou, Vassiliki Kazila, Polyzo Tsorlini, Helen Charalampaki, Nikoletta Toutouza, Marina Vagiakou, Helen Pappas, Konstantinos Kyratsa, Anna Kontopoulou, Konstantina Legga, Olga Petinaki, Efthymia Papadogeorgaki, Helen Chinou, Efrosini Souli, Maria Giamarellou, Helen |
author_facet | Galani, Irene Karaiskos, Ilias Karantani, Irene Papoutsaki, Vassiliki Maraki, Sofia Papaioannou, Vassiliki Kazila, Polyzo Tsorlini, Helen Charalampaki, Nikoletta Toutouza, Marina Vagiakou, Helen Pappas, Konstantinos Kyratsa, Anna Kontopoulou, Konstantina Legga, Olga Petinaki, Efthymia Papadogeorgaki, Helen Chinou, Efrosini Souli, Maria Giamarellou, Helen |
author_sort | Galani, Irene |
collection | PubMed |
description | A multicentre nationwide surveillance study was conducted in Greek hospitals to evaluate epidemiology of carbapenemase-producing Klebsiella pneumoniae clinical isolates, and their susceptibilities to last-line antibiotics. Methods: Minimum inhibitory concentrations (MICs) were evaluated by Etest, colistin MICs were also evaluated by broth microdilution SensiTest (now known as ComASP) Colistin. Carbapenemase genes were detected by PCR. Clonal relatedness was assessed by PFGE. Isolates were prospectively collected between November 2014 and April 2016, from 15 hospitals. Results: Among 394 isolates, K. pneumoniae carbepenemase (KPC) remained the most prevalent carbapenemase (66.5%). NDM was the second most prevalent (13.7%), identified in 12 hospitals, followed by VIM (8.6%). OXA-48- and double carbapenemase-producers remained rare (3.6%, 6.3%, respectively). Carbapenemase-producing K. pneumoniae isolates showed high resistance to last-line antibiotics. Gentamicin and colistin were the most active in vitro with 61.9% and 59.6% of the isolates to be inhibited at ≤ 2mg/L, followed by fosfomycin (susceptibility (S): 58.4%) and tigecycline (S: 51.5%). Ceftazidime/avibactam inhibited 99.6% of KPC and 100% of OXA-48-like-producing isolates, while temocillin was active against 58% of KPC isolates at urinary breakpoint of ≤ 32mg/L* and only 2.7% at systemic breakpoint of ≤ 8mg/L. NDM-producing isolates belonged mainly to one clone, whereas KPC, VIM, OXA-48 and double carbapenemase-producers were mainly polyclonal. Conclusions: KPC remains the predominant carbapenemase among K. pneumoniae in Greece, followed by NDM, whereas changing trends of resistance rates to last-line antimicrobials against carbapenemase-producing K. pneumoniae with the exception of ceftazidime/avibactam mandates continuing surveillance to support clinical practice. |
format | Online Article Text |
id | pubmed-6167611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-61676112018-10-12 Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016 Galani, Irene Karaiskos, Ilias Karantani, Irene Papoutsaki, Vassiliki Maraki, Sofia Papaioannou, Vassiliki Kazila, Polyzo Tsorlini, Helen Charalampaki, Nikoletta Toutouza, Marina Vagiakou, Helen Pappas, Konstantinos Kyratsa, Anna Kontopoulou, Konstantina Legga, Olga Petinaki, Efthymia Papadogeorgaki, Helen Chinou, Efrosini Souli, Maria Giamarellou, Helen Euro Surveill Research Article A multicentre nationwide surveillance study was conducted in Greek hospitals to evaluate epidemiology of carbapenemase-producing Klebsiella pneumoniae clinical isolates, and their susceptibilities to last-line antibiotics. Methods: Minimum inhibitory concentrations (MICs) were evaluated by Etest, colistin MICs were also evaluated by broth microdilution SensiTest (now known as ComASP) Colistin. Carbapenemase genes were detected by PCR. Clonal relatedness was assessed by PFGE. Isolates were prospectively collected between November 2014 and April 2016, from 15 hospitals. Results: Among 394 isolates, K. pneumoniae carbepenemase (KPC) remained the most prevalent carbapenemase (66.5%). NDM was the second most prevalent (13.7%), identified in 12 hospitals, followed by VIM (8.6%). OXA-48- and double carbapenemase-producers remained rare (3.6%, 6.3%, respectively). Carbapenemase-producing K. pneumoniae isolates showed high resistance to last-line antibiotics. Gentamicin and colistin were the most active in vitro with 61.9% and 59.6% of the isolates to be inhibited at ≤ 2mg/L, followed by fosfomycin (susceptibility (S): 58.4%) and tigecycline (S: 51.5%). Ceftazidime/avibactam inhibited 99.6% of KPC and 100% of OXA-48-like-producing isolates, while temocillin was active against 58% of KPC isolates at urinary breakpoint of ≤ 32mg/L* and only 2.7% at systemic breakpoint of ≤ 8mg/L. NDM-producing isolates belonged mainly to one clone, whereas KPC, VIM, OXA-48 and double carbapenemase-producers were mainly polyclonal. Conclusions: KPC remains the predominant carbapenemase among K. pneumoniae in Greece, followed by NDM, whereas changing trends of resistance rates to last-line antimicrobials against carbapenemase-producing K. pneumoniae with the exception of ceftazidime/avibactam mandates continuing surveillance to support clinical practice. European Centre for Disease Prevention and Control (ECDC) 2018-08-02 /pmc/articles/PMC6167611/ http://dx.doi.org/10.2807/1560-7917.ES.2018.23.31.1700775 Text en This article is copyright of The Authors, 2018. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Research Article Galani, Irene Karaiskos, Ilias Karantani, Irene Papoutsaki, Vassiliki Maraki, Sofia Papaioannou, Vassiliki Kazila, Polyzo Tsorlini, Helen Charalampaki, Nikoletta Toutouza, Marina Vagiakou, Helen Pappas, Konstantinos Kyratsa, Anna Kontopoulou, Konstantina Legga, Olga Petinaki, Efthymia Papadogeorgaki, Helen Chinou, Efrosini Souli, Maria Giamarellou, Helen Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016 |
title | Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016 |
title_full | Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016 |
title_fullStr | Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016 |
title_full_unstemmed | Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016 |
title_short | Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016 |
title_sort | epidemiology and resistance phenotypes of carbapenemase-producing klebsiella pneumoniae in greece, 2014 to 2016 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167611/ http://dx.doi.org/10.2807/1560-7917.ES.2018.23.31.1700775 |
work_keys_str_mv | AT galaniirene epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT karaiskosilias epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT karantaniirene epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT papoutsakivassiliki epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT marakisofia epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT papaioannouvassiliki epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT kazilapolyzo epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT tsorlinihelen epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT charalampakinikoletta epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT toutouzamarina epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT vagiakouhelen epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT pappaskonstantinos epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT kyratsaanna epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT kontopouloukonstantina epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT leggaolga epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT petinakiefthymia epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT papadogeorgakihelen epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT chinouefrosini epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT soulimaria epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT giamarellouhelen epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 AT epidemiologyandresistancephenotypesofcarbapenemaseproducingklebsiellapneumoniaeingreece2014to2016 |